Laddar...
Pragmatic use of insulin degludec/insulin aspart co-formulation: A multinational consensus statement
Insulin degludec/insulin aspart (IDegAsp) is a modern coformulation of ultra-long-acting basal insulin degludec, with rapid-acting insulin aspart. IDegAsp provides effective, safe, well-tolerated glycemic control, with a low risk of hypoglycemia while allowing flexibility in meal patterns and timing...
Sparad:
| I publikationen: | Indian J Endocrinol Metab |
|---|---|
| Huvudupphovsmän: | , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Medknow Publications & Media Pvt Ltd
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4911846/ https://ncbi.nlm.nih.gov/pubmed/27366723 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2230-8210.182980 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|